Skip to main content
. 2019 Oct 17;5(6):521–530. doi: 10.1002/osp4.366

Table 4.

Effectiveness outcomes (completers n = 27)

Baseline Follow‐up Deltaa % Change Range P Value
Weighta, kg 113.07 ± 25.4 110.8 ± 25.8 2.22 ± 3.18 −2.1 ± 3.0 −3.8, 9.6 <.001
Body mass index, kg/m2 41.3 ± 7.1 40.5 ± 7.3 −0.88 ±1.2 −2.1 ± 3.0% −1.65, 3.43 <.001
Waist circumferenceb, cm 120.6 ± 16.7 116.5 ± 17.0 −4.1 ± 5.9 −3.4 ± 5.0 −16.0, 8.0 .001
% pre/post Δ WC +7.5, −14.6
Body composition
Fat mass, % 49.2 ± 6.0 47.9 ± 6.6 −1.33 ± 1.13 −2.87 ± 2.53 −3.8, 1.0 <.001
Muscle mass, kg/height2 50.8 ± 6.0 52.1 ± 6.6 1.33 ± 1.13 +2.55 ± 2.17 −1, 3.8 <.001
ASM, kg 15.4 ± 3.35 15.7 ± 3.6 0.26 ± 0.57 1.7 ± 4.0% −3.7, 15.1 .03
Visceral fat, L 5.08 ± 3.16 4.48 ± 2.79 −0.60 ± 0.86 −12.4 ± 17.5 −2.8, 1.0 .001
6‐minute walk test, m 466.6 ± 105.4 484.6 ± 98.8 18.0 ± 59.5 4.9 ± 12.9 −16.7, 30.7 .55
% with >50 m improvement 7 (29.2)
30s sit‐to‐stand, # stands 16.2 ± 4.96 19.1 ± 7.3 2.46 ± 3.90 14.2 ± 20.1 −18.2, 50 .005
a

Delta represents only data on full data (baseline, follow‐up) of completers.

b

Missing data in n = 4 STS and n = 3 6mwt.